CLINICAL_TRIALS
trial_result
· 2019-06-24
Clinical Trial Update: A Trial of Everolimis in Patients With Advanced Renal Cell Carcinoma. [Phase 4]
Summary
Phase 4 clinical trial update for everolimus in advanced renal cell carcinoma, with completed status and results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Novartis Pharmaceuticals | Conditions: Renal Cell Carcinoma | Phase 4 | Status: COMPLETED | Results posted: 2019-06-24